Catalyst Wire Dossier Catalyst Wire Dossier

QVA149A

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QVA149A, covering 2014-02-12 to 2016-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation [Phase 3]

See pricing